TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/23 16:16 | 5/19/23 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Loewy Caroline M | DE | D | M.d | 0 | 0.00 | 0 | 4 | New | 4 | D | |||||||||||||||
3/6/08 18:33 | 3/6/08 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Loewy Caroline M | CA | O | CFO | P | 6 | 3.92 | 0 | 2 | 6 | 30 | I | ||||||||||||||
3/5/08 18:51 | 3/5/08 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Loewy Caroline M | CA | O | CFO | P | 33 | 3.74 | 0 | 9 | 45 | 28 | I | ||||||||||||||
3/5/08 17:43 | 3/4/08 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Loewy Caroline M | CA | O | CFO | P | 71 | 3.60 | 0 | 20 | New | 20 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |